biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > down 7%, now under .10 US. Congrats JD and other longs!

<< Previous

Bullboard Posts

Next >>

Comment by fatboy92on Jul 26, 2022 11:58am

85 Views

Post# 34851202

RE:down 7%, now under .10 US. Congrats JD and other longs!

You forgot to use your catch phrases. Stick a fork in this one, game over and flush this one down the toilet. Looks like your hard work over the last few years has paid off. You've achieved your goal, don't forget to pick up your paycheck on your way home.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China